Comera Life Sciences Holdings Inc. (NASDAQ: CMRA) stock fell -2.00% on Friday to $3.93 against a previous-day closing price of $4.01. With 4.29 million shares changed hands, the volume of the stock remained heavier than its average volume of 3.85 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $4.3500 whereas the lowest price it dropped to was $3.5500. The 52-week range on CMRA shows that it touched its highest point at $15.30 and its lowest point at $1.11 during that stretch.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CMRA was up-trending over the past week, with a rise of 112.43%, but this was up by 47.74% over a month. Three-month performance dropped to -61.64% while six-month performance fell -61.19%. The stock lost -60.58% in the past year, while it has lost -61.20% so far this year.
Float and Shares Shorts:
On Jul 14, 2022, short shares totaled 44760.0, which was 0.23% higher than short shares on Jun 14, 2022. In addition to Mr. Jeffrey S. Hackman as the firm’s Chairman, Pres & CEO, Dr. Neal I. Muni M.D., MSPH serves as its Exec. VP & COO.
Through their ownership of 81.35% of CMRA’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 56.63% of CMRA, in contrast to 0.13% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in CMRA with 5.19% of the stake, Boothbay Fund Management LLC holds 990,957 shares worth 990,957. A second-largest stockholder of CMRA, ATW SPAC Management LLC, holds 990,957 shares, controlling over 5.19% of the firm’s shares. Glazer Capital LLC is the third largest shareholder in CMRA, holding 887,724 shares or 4.65% stake. With a 0.10% stake in CMRA, the Picton Mahoney Fortified Arbitrag is the largest stakeholder. A total of 18,200 shares are owned by the mutual fund manager. The Fidelity Nasdaq Composite Index F, which owns about 0.02% of CMRA stock, is the second-largest Mutual Fund holder. It holds 4,547 shares valued at 12004.0. First Trust Alternative Opportuni holds 0.01% of the stake in CMRA, owning 1,936 shares worth 5111.0.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2022, CMRA reported revenue of $95.33k and operating income of -$2.45M. Over the past year, revenue came in at $319.83k while operating income stood at -$5.54M. It generated -$2.88M net income for the quarter, which came to -$5.45M over the last twelve months. The EBITDA in the recently reported quarter was -$2.85M and diluted EPS was -$0.15. EBITDA for the full year was -$5.61M.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CMRA since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With CMRA analysts setting a high price target of – and a low target of –, the average target price over the next 12 months is –.